Taylor & Francis | Hematology Journals | Submit Today

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Hematology

Publish open access with Taylor & Francis

Explore Portfolio

Looking to publish your next article?

Find the perfect home for your research. This portfolio consists of notably indexed, peer-reviewed, fully open access journals and hybrid journals, where you can choose to publish open access; aiming to serve both the academic research community and practitioner community.

The below journals have various specialties in:

  • general hematology
  • solid or hematological cancers
  • platelet and megakaryocyte related research
  • tumor immunology
  • all aspects of oncogenesis
  • hemoglobin in humans and other species
  • pediatric research in blood disorders

Find out if your institution or country has an open access agreement to publish with us.

Publishing open access increases the visibility and readership of your research, helping you make an impact beyond your field.
Find Out More

Hematology

2019 Impact Factor 1.650
Five-Year Impact Factor 1.406

Hematology publishes articles on hematology with interdisciplinary approach including epidemiology, oncology, pathology, biology, clinical cancer research and management.

Visit Journal Submit

Leukemia & Lymphoma

2019 Impact Factor 2.969
Five-Year Impact Factor 2.570

Leukemia & Lymphoma publishes research on hematological cancers, covering disease biology, novel agents, chemotherapy, pharmacology/pharmacogenomics, ethics and epidemiology.

Visit Journal Submit


 

Platelets

2019 Impact Factor 3.378
Five-Year Impact Factor 2.912

This journal publishes platelet and megakaryocyte related research including platelet function, pharmacology and therapeutics.

Visit Journal Submit

OncoImmunology

2019 Impact Factor 5.869
Five-Year Impact Factor 6.255

Oncoimmunology publishes international translational and clinical research into tumor immunology including anticancer therapies and immunotherapies.

Visit Journal Submit


 

Molecular & Cellular Oncology

2019 CiteScore 2.4

This journal publishes original papers, reviews, perspectives and commentaries on oncogenesis, tumor progression and therapeutics for solid and hematological cancers.

Visit Journal Submit

Nutrition and Cancer

2019 Impact Factor 2.363
Five-Year Impact Factor 2.533

Nutrition and Cancer publishes research on the impact of nutrition on cancer etiology, therapy, and prevention, covering topics like, carcinogenesis, dietetics, and food policies.

Visit Journal Submit


 

Cancer Biology & Therapy

2019 Impact Factor 3.659
Five-Year Impact Factor 3.715

This journal publishes articles on the molecular basis of cancer, including translational diagnostic relevance or therapy, reviews, op-ed pieces and meeting reports.

Visit Journal Submit

Electromagnetic Biology and Medicine

2019 Impact Factor 1.820
Five-Year Impact Factor 1.490

This journal considers in vivo, in vitro, epidemiological and other studies on non-ionizing electromagnetic fields and its biological effect and medical applications.

Visit Journal Submit


 

Hemoglobin

2019 Impact Factor 0.526
Five-Year Impact Factor 0.732

Hemoglobin publishes research on hemoglobin in humans and other species, including genetics and biochemistry, treatment of thalassemias, and neonatal/adult screening.

Visit Journal Submit

Pediatric Hematology and Oncology

2019 Impact Factor 1.232
Five-Year Impact Factor 1.318

This journal publishes pediatric research in blood disorders and malignancies, including pharmacology, stem cells, molecular targeting, immune therapies & transplantation.

Visit Journal Submit

Questions about the publishing process?

Visit our dedicated and ever-expanding site for authors, Author Services, to find out more about how to get published and your publishing options.
Find Out More

SHARE THIS PAGE

F1000Research is an Open Research publishing platform for scientists, scholars and clinicians, supporting data deposition and sharing. Publish all your findings including null results, data notes and more.
Go To F1000Research
Dove Medical Press is part of the Taylor & Francis Group, specializing in the publication of Open Access peer-reviewed journals across the broad spectrum of science, technology and especially medicine.
Go To Dove Press

Latest tweets from @tandfmedicine